Skip to main content

Table 2 Different pathological types and subtypes of the study population

From: Comparison between RECIST and PERCIST criteria in therapeutic response assessment in cases of lymphoma

 

Pathology

No. of patients

Types

NHL

15 (45.5%)

HL

17 (51.5%)

GALT

1 (3.0%)

Subtypes

NHL-DLBCL

12 (36.4%)

NHL-TCL

1 (3%)

NHL-F

2 (6%)

HL-NS

10 (30.3%)

HL-MC

5 (15.2%)

HL-LP

2 (6%)

GALT

1 (3%)